Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion

Figure 1

Mean treprostinil plasma concentration versus time curves following repeat doses of 2 mg BID and 4 mg BID of treprostinil diethanolamine SR in SSc patients. Dose-related increases in treprostinil concentrations were observed over the 0 to 12 hour post-dose period. Bars represent the standard error of the mean. BID, twice daily; SR, sustained release; SSc, systemic sclerosis.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us